Xanthine Oxidase Inhibitors in Heart Failure: Where Do We Go From Here?
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Oxidation of tyrosine phosphatases by peroxynitrite results in the inhibition of their enzymatic activity and the aberrant propagation of phosphorylative signaling.
“Oxidation of tyrosine phosphatases results in the inhibition of their enzymatic activity and the aberrant propagation of phosphorylative signaling (926).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [926]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 24 · Cited by 39
- Authors
- Tamariz, L., & Hare, J. M.
- Affiliations
- University of Miami (US)
- Venue
- Circulation
- Published
- 2015-05-19
- Volume
- 131
- Issue
- 20
- Pages
- 1741-1744
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC4438774
- OpenAlex
- W2065947013
- Cited by
- 39
- References
- 24
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 2
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (5UMHL113460)
- National Heart, Lung, and Blood Institute (R01HL110737, R01HL084275, UM1HL113460, R01HL107110)
- Topics
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- xanthine oxidase inhibitors, heart failure, uric acid, xanthine oxidase, urate-lowering therapy
- MeSH terms
- Allopurinol, Female, Heart Failure, Humans, Male, Xanthine Oxidase, Hyperuricemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
